Artificial Intelligence | Machine Learning | Natural Language Processing Biotia | Hospital-Acquired Infections Solution


Enterprise, Infectious Disease, Bioinformatics, Biotechnology, Digital Health New York , United States

Biotia

Artificial Intelligence | Machine Learning | Natural Language Processing


Biotia | Hospital-Acquired Infections Solution

Biotia

Infectious Disease, Bioinformatics, Biotechnology, Digital Health


New York , United States

Biotia is a biotechnology company providing hospitals with tailored sequencing-based solutions to reduce hospital-acquired infections. Using sequencing and proprietary bioinformatics technology, we help hospitals to fight nosocomial infections and other diseases. Founded by Dr. O'Hara, Dr. Mason and Dr. Ounit, Biotia offers an active surveillance of the highest risk units, and incoming patients, and facilitating intervention before patients get sick.Diagnosing and researching infectious disease is challenging, with a high rate of diagnostic failure resulting in high mortality and alarming levels of drug resistance. Culturing, the current gold standard and technology from the 1800s, misses many important pathogens and requires many labor intensive tests. Even newer PCR-based tests are limited, problematic and don’t provide drug resistance information.We work with hospitals and researchers to leverage high-complexity tests and artificial intelligence for rapid precision infectious disease diagnostics to guide patient treatment and improve health outcomes. Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid precision infectious disease discovery. Our software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.

 

B2B

1 to 25

Series A

$10.4 M

Scaling Up

2016

 
 

Healthcare
Health Care Facilities & Hospitals

Improve Health Outcomes
Leverage High-Complexity Tests

Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Natural Language Processing


Biomedical Insights

Biomedical Insights

Digital Health

Digital Health


Image

Image

Video

Video

Text

Text

Structured

Structured

 

   Software


Python

Python

Kubernetes

Kubernetes

.Net Core Stack

.Net Core Stack

C/C++

C/C++

Pytorch

Pytorch

NoSQL

NoSQL

Tensorflow

Tensorflow


3D Mapping Algorithms

3D Mapping Algorithms

Machine Learning Algorithm

Machine Learning Algorithm

Computer Vision Algorithm

Computer Vision Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

View All

NYS Lead Clinical Laboratory Technologist

Brooklyn, New York

Director of Sales and Business Development

New York, New York

 

AI/ML Professionals

Want to work at Biotia?

We can introduce you to the right person at Biotia

Talk to our Talent Team

 

11

1

$8M

Company was founded 2016 and it took almost 6 years (Aug 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

08/23/2022

Series A

$8M

OCA Ventures, Continuum Health Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Digital-Dx Ventures, Falcon II Ventures, Tau Ventures, Hyperplane Venture Capital, Leawood Venture Capital, SpringTide Ventures

Date : 08/23/2022

Round: Series A

$ Raised: $8M

Investors: OCA Ventures, Continuum Health Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Digital-Dx Ventures, Falcon II Ventures, Tau Ventures, Hyperplane Venture Capital, Leawood Venture Capital, SpringTide Ventures

 

Investors

Interested in researching Biotia?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Biotia

Request a Demo - Deal Souring Platform

 
Niamh B. O'Hara


Niamh B. O'Hara
Co-Founder & CEO

Christopher Mason


Christopher Mason
Co-Founder

David Danko

David Danko
Chief Technology Officer

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Biotia